Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE


Phase N/A Results

Summary of Purpose

This purpose of this study is to collect data on the FDA-approved ACCULINK(TM) Carotid Stent System and FDA 510(k)-cleared ACCUNET(TM) Embolic Protection System for the treatment of patients with atherosclerotic disease, when used by physicians under commercial use conditions.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 October 2008.

1 Oct 2004 13 Sep 2005 1 Dec 2006 1 Aug 2007 1 Oct 2008 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment


Not available